Quality by Design Optimization of Cold Sonochemical Synthesis of Zidovudine-Lamivudine Nanosuspensions
Open Access
- 17 April 2020
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (4) , 367
Abstract
Lamivudine (3TC) and zidovudine (AZT) are antiviral agents used to manage HIV/AIDS infection. The compounds require frequent dosing, exhibit unpredictable bioavailability and a side effect profile that includes hepato- and haema-toxicity. A novel pseudo one-solvent bottom-up approach and Design of Experiments using sodium dodecyl sulphate (SDS) and α-tocopheryl polyethylene glycol succinate 1000 (TPGS 1000) to electrosterically stablize the nano co-crystals was used to develop, produce and optimize 3TC and AZT nano co-crystals. Equimolar solutions of 3TC in surfactant dissolved in de-ionised water and AZT in methanol were rapidly injected into a vessel and sonicated at 4 °C. The resultant suspensions were characterized using a Zetasizer and the particle size, polydispersity index and Zeta potential determined. Optimization of the nanosuspensions was conducted using a Central Composite Design to produce nano co-crystals with specific identified and desirable Critical Quality Attributes including particle size (PS) < 1000 nm, polydispersity index (PDI) < 0.500 and Zeta potential (ZP) < −30mV. Further characterization was undertaken using Fourier Transform infrared spectroscopy, energy dispersive X-ray spectroscopy, differential scanning calorimetry, powder X-ray diffraction and transmission electron microscopy. In vitro cytotoxicity studies revealed that the optimized nano co-crystals reduced the toxicity of AZT and 3TC to HeLa cells.Keywords
This publication has 65 references indexed in Scilit:
- Drug-drug co-crystalsDARU Journal of Pharmaceutical Sciences, 2012
- Macrophages and their relevance in Human Immunodeficiency Virus Type I infectionRetrovirology, 2012
- Targeted Liposomal Drug Delivery to Monocytes and MacrophagesJournal of Drug Delivery, 2010
- Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral FormulationAntimicrobial Agents and Chemotherapy, 2010
- Nanoformulated Antiretroviral Drug Combinations Extend Drug Release and Antiretroviral Responses in HIV-1-Infected Macrophages: Implications for NeuroAIDS TherapeuticsJournal of Neuroimmune Pharmacology, 2010
- Cyclosporine A-Nanosuspension: Formulation, Characterization and In Vivo Comparison with a Marketed FormulationScientia Pharmaceutica, 2010
- The melting behavior of aluminum nanoparticlesThermochimica Acta, 2007
- Size-dependent melting and supercooling of Ge nanoparticles embedded in a SiO2 thin filmThermochimica Acta, 2007
- Sheddable Coatings for Long-Circulating NanoparticlesPharmaceutical Research, 2007
- Critical review of methods for the determination of purity by differential scanning calorimetry*Thermochimica Acta, 1976